{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:55:58Z","timestamp":1776128158048,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T00:00:00Z","timestamp":1278806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s12020-010-9373-x","type":"journal-article","created":{"date-parts":[[2010,7,11]],"date-time":"2010-07-11T22:49:05Z","timestamp":1278888545000},"page":"199-205","source":"Crossref","is-referenced-by-count":6,"title":["A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism"],"prefix":"10.1007","volume":"38","author":[{"given":"Turan","family":"\u00c7alhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebubekir","family":"\u015eenate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egemen","family":"Cebeci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayid Shafi","family":"Zuhur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"\u00d6zbak\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U\u011fur","family":"G\u00f6rpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,11]]},"reference":[{"issue":"17","key":"9373_CR1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","volume":"343","author":"AP Weetman","year":"2000","unstructured":"A.P. Weetman, Graves\u2019 disease. N. Engl. J. Med. 343(17), 1236\u20131248 (2000)","journal-title":"N. Engl. J. Med."},{"key":"9373_CR2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF03344152","volume":"29","author":"K Gungor","year":"2006","unstructured":"K. Gungor, S. Gonen, G. Kisakol, O. Dikbas, A. Kaya, ANCA positive propylthiouracil induced pyoderma gangrenosum. J. Endocrinol. Invest. 29, 575\u2013576 (2006)","journal-title":"J. Endocrinol. Invest."},{"key":"9373_CR3","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/jc.2002-021383","volume":"88","author":"M Gum\u00e0","year":"2003","unstructured":"M. Gum\u00e0, I. Salinas, J.L. Reverter, J. Roca, M. Valls-Roc, M. Juan, A. Oliv\u00e9, Frequency of antineutrophil cytoplasmic antibody in Graves\u2019 disease patients treated with methimazole. J. Clin. Endocrinol. Metab. 88, 2141\u20132146 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9373_CR4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2265.2007.02770.x","volume":"66","author":"Y Gao","year":"2007","unstructured":"Y. Gao, M. Chen, H. Ye, X.H. Guo, M.H. Zhao, H.Y. Wang, Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis. Clin. Endocrinol. (Oxf) 66, 543\u2013547 (2007)","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"9373_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/jc.84.1.13","volume":"84","author":"JE Gunton","year":"1999","unstructured":"J.E. Gunton, J. Stiel, R.J. Caterson, A. McElduff, Clinical case seminar: antithyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J. Clin. Endocrinol. Metab. 84, 13\u201316 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9373_CR6","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1093\/ndt\/gfm493","volume":"22","author":"S Lionaki","year":"2007","unstructured":"S. Lionaki, S.L. Hogan, R.J. Falk, M.S. Joy, H. Chin, C.E. Jennette, J.C. Jennette, P.H. Nachman, Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. Nephrol. Dial. Transplant. 22, 3508\u20133515 (2007)","journal-title":"Nephrol. Dial. Transplant."},{"key":"9373_CR7","doi-asserted-by":"crossref","first-page":"R1072","DOI":"10.1186\/ar1789","volume":"7","author":"B Bonaci-Nikolic","year":"2005","unstructured":"B. Bonaci-Nikolic, M.M. Nikolic, S. Andrejevic, S. Zoric, M. Bukilica, Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res. Ther. 7, R1072\u2013R1081 (2005)","journal-title":"Arthritis Res. Ther."},{"key":"9373_CR8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/thy.2008.0121","volume":"18","author":"PF Tripodi","year":"2008","unstructured":"P.F. Tripodi, R.M. Ruggeri, A. Campenni, Central nervous system vasculitis after starting methimazole in a woman with Graves\u2019 disease. Thyroid 18, 1011\u20131013 (2008)","journal-title":"Thyroid"},{"key":"9373_CR9","first-page":"149","volume":"15","author":"T Bak\u0131rc\u0131","year":"2004","unstructured":"T. Bak\u0131rc\u0131, K. Nilg\u00fcn ve ark, A case of propylthiouracil-induced alveolar haemorrhage (article in Turkish language). Solunum Hastal\u0131klar\u0131 15, 149\u2013153 (2004)","journal-title":"Solunum Hastal\u0131klar\u0131"},{"key":"9373_CR10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1183\/09031936.97.10061405","volume":"10","author":"M Ohtsuka","year":"1997","unstructured":"M. Ohtsuka, Y. Yamashita, M. Doi, S. Hasegawa, Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur. Respir. J. 10, 1405\u20131407 (1997)","journal-title":"Eur. Respir. J."},{"key":"9373_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2329\/perio.39.167","volume":"39","author":"T Saeki","year":"1997","unstructured":"T. Saeki, S. Miyamura, M. Nakano, M. Arakawa, A case of Grave\u2019s disease with MPO-ANCA-associated glomerulonephritis during propylthiouracil (PTU) therapy following interstitial pneumonitis. Nippon Jinzo Gakkai Shi 39, 167\u2013171 (1997)","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"9373_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0167-5699(91)90159-Q","volume":"12","author":"CG Kallenberg","year":"1991","unstructured":"C.G. Kallenberg, J.W. Tervaert, F.J. van der Woude, R. Goldschmeding, A.E. Von dem Borne, J.J. Weening, Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol. Today 12, 61\u201364 (1991)","journal-title":"Immunol. Today"},{"key":"9373_CR13","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","volume":"337","author":"JC Jennette","year":"1997","unstructured":"J.C. Jennette, R.J. Falk, Small-vessel vasculitis. N. Engl. J. Med. 337, 1512\u20131523 (1997)","journal-title":"N. Engl. J. Med."},{"key":"9373_CR14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)91761-A","volume":"342","author":"KM Dolman","year":"1993","unstructured":"K.M. Dolman, R.O. Gans, T.J. Vervaat, G. Zevenbergen, D. Maingay, R.E. Nikkels, A.J. Donker, A.E. von dem Borne, R. Goldschmeding, Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342, 651\u2013652 (1993)","journal-title":"Lancet"},{"key":"9373_CR15","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3476(05)83199-3","volume":"124","author":"BA Vogt","year":"1994","unstructured":"B.A. Vogt, Y. Kim, J.C. Jennette, R.J. Falk, B.A. Burke, A. Sinaiko, Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J. Pediatr. 124, 986\u2013988 (1994)","journal-title":"J. Pediatr."},{"key":"9373_CR16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/0272-6386(95)90441-7","volume":"26","author":"M Tanemoto","year":"1995","unstructured":"M. Tanemoto, H. Miyakawa, J. Hanai, M. Yago, M. Kitaoka, S. Uchida, Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves\u2019 disease: report of three adult cases. Am. J. Kidney Dis. 26, 774\u2013780 (1995)","journal-title":"Am. J. Kidney Dis."},{"key":"9373_CR17","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1378\/chest.102.5.1595","volume":"102","author":"SJ Stankus","year":"1992","unstructured":"S.J. Stankus, N.T. Johnson, Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 102, 1595\u20131596 (1992)","journal-title":"Chest"},{"key":"9373_CR18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/rheumatology\/34.11.1090","volume":"34","author":"D D\u2019Cruz","year":"1995","unstructured":"D. D\u2019Cruz, A.M. Chesser, C. Lightowler, M. Comer, M.J. Hurst, L.R. Baker, A.E. Raine, Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with antithyroid drug treatment. Br. J. Rheumatol. 34, 1090\u20131091 (1995)","journal-title":"Br. J. Rheumatol."},{"key":"9373_CR19","first-page":"336","volume":"47","author":"T Kitahara","year":"1997","unstructured":"T. Kitahara, K. Hiromura, A. Maezawa, K. Ono, N. Narabara, S. Yano, T. Naruse, K. Takenouchi, Y. Yasumoto, Case of propylthiouracil-induced vasculitis associated with antineutrophil cytoplasmic antibody (ANCA); review of literature. Clin. Nephrol. 47, 336\u2013340 (1997)","journal-title":"Clin. Nephrol."},{"key":"9373_CR20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1159\/000189164","volume":"73","author":"S Yuasa","year":"1996","unstructured":"S. Yuasa, M. Hashimoto, T. Yura, T. Sumikura, N. Takahashi, T. Shoji, K. Uchida, H. Fujioka, M. Kihara, H. Matsuo, Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy. Nephron 73, 701\u2013703 (1996)","journal-title":"Nephron"},{"key":"9373_CR21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2230.1995.tb01340.x","volume":"20","author":"Y Kawachi","year":"1995","unstructured":"Y. Kawachi, H. Nukaga, M. Hoshino, M. Iwata, F. Otsuka, ANCA-associated vasculitis and lupus-like syndrome caused by methimazole. Clin. Exp. Dermatol. 20, 345\u2013347 (1995)","journal-title":"Clin. Exp. Dermatol."},{"key":"9373_CR22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1420587","volume":"142","author":"JE Gunton","year":"2000","unstructured":"J.E. Gunton, J. Stiel, P. Clifton-Bligh, E. Wilmshurst, A. McElduff, Prevalence of positive antineutrophil cytoplasmic antibody (ANCA) in patients receiving antithyroid medication. Eur. J. Endocrinol. 142, 587 (2000)","journal-title":"Eur. J. Endocrinol."},{"key":"9373_CR23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1507\/endocrj.49.329","volume":"49","author":"N Wada","year":"2002","unstructured":"N. Wada, M. Mukai, M. Kohno, A. Notoya, T. Ito, N. Yoshioka, Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves\u2019 disease treated with propylthiouracil and thiamazole. Endocr. J. 49, 329\u2013334 (2002)","journal-title":"Endocr. J."},{"key":"9373_CR24","unstructured":"Ayd\u0131ntu\u011f Olca (1992) Antineutrophil cytoplasmic antibody (ANCA) and associated diseases (article in Turkish language), \u0130mm\u00fcnoloji Romatoloji, T Klin T\u0131p Bilimleri 12."},{"key":"9373_CR25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1681\/ASN.V132437","volume":"13","author":"M Fujieda","year":"2002","unstructured":"M. Fujieda, M. Hattori, H. Kurayama, Y. Koitabashi, Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J. Am. Soc. Nephrol. 13, 437\u2013445 (2002)","journal-title":"J. Am. Soc. Nephrol."},{"key":"9373_CR26","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.149.11.2461","volume":"149","author":"JW Cohen Tervaert","year":"1989","unstructured":"J.W. Cohen Tervaert, F.J. Van der Woude, A.S. Fauci et al., Association between active Wegener\u2019s granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149, 2461\u20132465 (1989)","journal-title":"Arch Intern Med"},{"key":"9373_CR27","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1210\/jc.85.11.4270","volume":"85","author":"H Sato","year":"2000","unstructured":"H. Sato, M. Hattori, M. Fujieda, S. Sugihara, H. Inomata, M. Hoshi, S. Miyamoto, High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves\u2019 disease treated with propylthiouracil. J. Clin. Endocrinol. Metab. 85, 4270\u20134273 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9373_CR28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMcpc020104","volume":"347","author":"M Simon","year":"2002","unstructured":"M. Simon, R. Helfgott, N. Smith, Case Records of The Massachusetts General Hospital Weekly clinicopathological exercises. Case 21-2002. A 21-year-old man with arthritis during treatment for hyperthyroidism. N. Engl. J. Med. 347, 122\u2013130 (2002)","journal-title":"N. Engl. J. Med."},{"key":"9373_CR29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.2004.02029.x","volume":"60","author":"L Harper","year":"2004","unstructured":"L. Harper, L. Chin, J. Daykin, A. Allahabadia, J. Heward, S.C. Gough, C.O. Savage, J.A. Franklyn, Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies(ANCA) in patients with Graves\u2019 disease. Clin Endocrinol (Oxf) 60, 671\u2013675 (2004)","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"9373_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.intimp.2006.07.033","volume":"7","author":"Y Gao","year":"2007","unstructured":"Y. Gao, M. Chen, H. Ye, X.H. Guo, M.H. Zhao, H.Y. Wang, The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Int. Immunopharmacol. 7, 55\u201360 (2007)","journal-title":"Int. Immunopharmacol."},{"key":"9373_CR31","first-page":"296","volume":"61","author":"EM Jacobs","year":"2003","unstructured":"E.M. Jacobs, A. Hartkamp, H.A. Kaasjager, PTU-associated cutaneous vasculitis with ANCA anti-MPO and anti-PR3 antibodies. Neth. J. Med. 61, 296\u2013299 (2003)","journal-title":"Neth. J. Med."},{"key":"9373_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/07435809809135527","volume":"24","author":"A Afeltra","year":"1998","unstructured":"A. Afeltra, A. Paggi, F.G. De Rosa, P. Manfredini, M.A. Addessi, A. Amoroso, Antineutrophil cytoplasmic antibodies in autoimmune thyroid disorders. Endocr. Res. 24, 185\u2013194 (1998)","journal-title":"Endocr. Res."},{"key":"9373_CR33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/thy.2000.10.595","volume":"10","author":"N Sera","year":"2000","unstructured":"N. Sera, K. Ashizawa, T. Ando et al., Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves\u2019 disease. Thyroid 10, 595\u2013599 (2000)","journal-title":"Thyroid"},{"key":"9373_CR34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2265.2001.01282.x","volume":"54","author":"JY Noh","year":"2001","unstructured":"J.Y. Noh, T. Asari, N. Hamada et al., Frequency of appearance of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves\u2019 disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin. Endocrinol. (Oxf) 54, 651\u2013654 (2001)","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9373_CR35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1081\/ERC-120037729","volume":"30","author":"Y Gao","year":"2004","unstructured":"Y. Gao, M.H. Zhao, X.H. Guo, G. Xin, H.Y. Wang, The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr. Res. 30, 205\u2013213 (2004)","journal-title":"Endocr. Res."},{"issue":"7","key":"9373_CR36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","volume":"19","author":"RS Bahn","year":"2009","unstructured":"R.S. Bahn, H.S. Burch, D.S. Cooper, J.R. Garber, C.M. Greenlee, I.L. Klein et al., The role of propylthiouracil in the management of Graves\u2019 disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 19(7), 673\u2013674 (2009)","journal-title":"Thyroid"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-010-9373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-010-9373-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-010-9373-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T06:09:44Z","timestamp":1711606184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-010-9373-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["9373"],"URL":"https:\/\/doi.org\/10.1007\/s12020-010-9373-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,11]]}}}